SEC Form 4 · accession 0001232524-15-000107
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Gray
Director
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 7:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 12, 2015 | S | 697 | $173.85 | D | 4,953 | D | |
| Ordinary Shares | May 12, 2015 | S | 7 | $175.15 | D | 4,946 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.